Drug profile · INN
polyethylene
polyethylene is an FDA-listed pharmaceutical active ingredient.
Drug details — polyethylene
- Class
- —
- Route
- —
- Patents
- 11
- Programs
- 4
- Data quality
- 0.70
Quick answer
polyethylene is an FDA-listed pharmaceutical active ingredient.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Pipeline programs
Related patents
-
US 12011450
Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof
granted -
US 11890353
Anti-polyethylene glycol (PEG) antibody mouse model for rigorous assessment of PEG-based therapies
granted -
US 11583541
Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof
granted -
US 10933071
Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof
granted -
US 10485809
Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof
granted -
US 9150837
Polyethylene glycolated superoxide dismutase mimetics
granted -
US 8901277
Interferon alpha mutant and its polyethylene glycol derivative
granted -
US 8217166
Polyethylene glycolated superoxide dismutase mimetics
granted -
US 8168751
Interferon alpha mutant and its polyethylene glycol derivative
granted -
US 7223803
Polyethylene (glycol) derivatives with proximal reactive groups
granted -
US 7030278
Polyethylene(Glycol) derivatives with proximal reactive groups
expired
Frequently asked questions
What is polyethylene?
polyethylene is an FDA-listed pharmaceutical active ingredient.